171.38
price down icon1.32%   -2.30
after-market 시간 외 거래: 169.55 -1.83 -1.07%
loading
전일 마감가:
$173.68
열려 있는:
$172.91
하루 거래량:
746.45K
Relative Volume:
0.57
시가총액:
$19.13B
수익:
$9.54B
순이익/손실:
$841.00M
주가수익비율:
23.03
EPS:
7.44
순현금흐름:
$1.02B
1주 성능:
+0.53%
1개월 성능:
-3.00%
6개월 성능:
+4.94%
1년 성능:
+23.37%
1일 변동 폭
Value
$171.00
$173.67
1주일 범위
Value
$168.46
$173.95
52주 변동 폭
Value
$135.47
$179.99

퀘스트 다이아그노스틱스 Stock (DGX) Company Profile

Name
명칭
Quest Diagnostics Inc
Name
전화
(973) 520-2700
Name
주소
500 PLAZA DRIVE, SECAUCUS
Name
직원
56,000
Name
트위터
@QuestDX
Name
다음 수익 날짜
2025-04-22
Name
최신 SEC 제출 서류
Name
DGX's Discussions on Twitter

DGX을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Diagnostics & Research icon
DGX
Quest Diagnostics Inc
171.38 19.90B 9.54B 841.00M 1.02B 7.44
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
402.13 156.19B 42.90B 6.52B 6.72B 17.05
Diagnostics & Research icon
DHR
Danaher Corp
189.01 141.54B 23.82B 3.77B 4.90B 5.15
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
514.33 41.59B 3.93B 894.97M 837.70M 10.82
Diagnostics & Research icon
A
Agilent Technologies Inc
110.88 32.35B 6.53B 1.26B 1.31B 4.35
Diagnostics & Research icon
MTD
Mettler Toledo International Inc
1,157.50 24.65B 3.87B 863.14M 864.45M 40.53

퀘스트 다이아그노스틱스 Stock (DGX) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-04-02 개시 Redburn Atlantic Buy
2025-03-04 다운그레이드 Citigroup Buy → Neutral
2025-01-06 업그레이드 Leerink Partners Market Perform → Outperform
2024-12-17 업그레이드 Morgan Stanley Equal-Weight → Overweight
2024-12-10 재개 Jefferies Buy
2024-10-23 업그레이드 Robert W. Baird Neutral → Outperform
2024-08-28 재개 Evercore ISI In-line
2024-07-10 업그레이드 Citigroup Neutral → Buy
2024-02-26 개시 Leerink Partners Market Perform
2024-02-07 업그레이드 Jefferies Hold → Buy
2024-01-03 개시 Barclays Equal Weight
2023-12-12 업그레이드 BofA Securities Neutral → Buy
2023-06-29 개시 Piper Sandler Neutral
2023-05-02 다운그레이드 BofA Securities Buy → Neutral
2023-04-03 업그레이드 Citigroup Sell → Neutral
2023-01-23 개시 Evercore ISI In-line
2022-11-17 다운그레이드 Citigroup Neutral → Sell
2022-08-22 재개 Morgan Stanley Equal-Weight
2022-04-04 다운그레이드 Citigroup Buy → Neutral
2022-02-23 다운그레이드 UBS Buy → Neutral
2022-02-02 다운그레이드 Jefferies Buy → Hold
2022-01-28 다운그레이드 Deutsche Bank Buy → Hold
2021-05-04 업그레이드 UBS Neutral → Buy
2021-03-12 다운그레이드 Robert W. Baird Outperform → Neutral
2020-10-21 업그레이드 Argus Hold → Buy
2020-07-29 업그레이드 KeyBanc Capital Markets Sector Weight → Overweight
2020-07-14 업그레이드 BofA Securities Neutral → Buy
2020-06-09 업그레이드 Wells Fargo Underweight → Equal Weight
2020-06-02 업그레이드 Deutsche Bank Hold → Buy
2020-04-28 업그레이드 Morgan Stanley Equal-Weight → Overweight
2020-04-27 업그레이드 Citigroup Neutral → Buy
2020-04-27 업그레이드 Wolfe Research Underperform → Peer Perform
2020-03-27 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2020-01-08 개시 Wells Fargo Underweight
2020-01-07 다운그레이드 Barclays Overweight → Equal Weight
2019-12-19 업그레이드 BofA/Merrill Underperform → Neutral
2019-07-15 다운그레이드 Goldman Neutral → Sell
2019-04-02 업그레이드 Jefferies Hold → Buy
2019-03-18 재개 Credit Suisse Neutral
2019-01-31 다운그레이드 Argus Buy → Hold
2019-01-17 개시 UBS Neutral
2019-01-03 다운그레이드 BofA/Merrill Neutral → Underperform
2018-12-03 다운그레이드 BofA/Merrill Buy → Neutral
2018-11-30 다운그레이드 Goldman Buy → Neutral
모두보기

퀘스트 다이아그노스틱스 주식(DGX)의 최신 뉴스

pulisher
May 27, 2025

Quest Diagnostics (DGX) Participates in Upcoming Oppenheimer Meeting | DGX Stock News - GuruFocus

May 27, 2025
pulisher
May 27, 2025

HOLX vs. DGX: Which Women's Health-Focused Stock Is the Better Pick? - The Globe and Mail

May 27, 2025
pulisher
May 23, 2025

Is Wall Street Bullish or Bearish on Quest Diagnostics Stock? - Inkl

May 23, 2025
pulisher
May 23, 2025

Is Wall Street Bullish Or Bearish On Quest Diagnostics Stock? - Barchart.com

May 23, 2025
pulisher
May 22, 2025

Quest Diagnostics' $4M Rest Break Settlement Gets Initial OK - Law360

May 22, 2025
pulisher
May 22, 2025

Quest Diagnostics (DGX) Announces Results of 2025 Annual Meeting of Stockholders - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Quest Diagnostics Inc (DGX) Shares Gap Down to $171.44 on May 21 - GuruFocus

May 22, 2025
pulisher
May 21, 2025

What's Driving Quest Diagnostics Stock's 25.6% Rally in a Year? - Yahoo Finance

May 21, 2025
pulisher
May 20, 2025

Quest Diagnostics stock hits all-time high of $179.37 By Investing.com - Investing.com Nigeria

May 20, 2025
pulisher
May 19, 2025

Director Diaz Luis was granted 1,203 shares, increasing direct ownership by 42% to 4,054 units (SEC Form 4) - Quantisnow

May 19, 2025
pulisher
May 16, 2025

Quest Diagnostics to Speak at the William Blair 45th Annual Growth Stock Conference - PR Newswire

May 16, 2025
pulisher
May 16, 2025

Lung Cancer Diagnostics Market Outlook: Opportunities in Early - openPR.com

May 16, 2025
pulisher
May 16, 2025

Here's Why Quest Diagnostics (DGX) is a Strong Momentum Stock - Yahoo Finance

May 16, 2025
pulisher
May 16, 2025

Quest Diagnostics CEO Reveals Future Growth Strategy: Key Insights Coming at William Blair Conference - Stock Titan

May 16, 2025
pulisher
May 15, 2025

Here's Why Quest Diagnostics (DGX) is a Strong Value Stock - Yahoo Finance

May 15, 2025
pulisher
May 15, 2025

Insider Sell: Mark Delaney Sells Shares of Quest Diagnostics Inc (DGX) - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Quest Diagnostics Keeps Dividend at $0.80 per Share, Payable July 21 to Shareholders as of July 7 - marketscreener.com

May 15, 2025
pulisher
May 15, 2025

Quest Diagnostics (DGX) Declares Consistent Dividend - GuruFocus

May 15, 2025
pulisher
May 14, 2025

Quest Diagnostics Declares Quarterly Cash Dividend, Payable on July 21, 2025 - marketscreener.com

May 14, 2025
pulisher
May 14, 2025

Quest Diagnostics : Forbes Names Quest Diagnostics One of America's Best Large Employers - marketscreener.com

May 14, 2025
pulisher
May 13, 2025

Is Quest Diagnostics Incorporated's (NYSE:DGX) Recent Stock Performance Influenced By Its Fundamentals In Any Way? - Yahoo

May 13, 2025
pulisher
May 13, 2025

Should You Continue to Retain DGX Stock in Your Portfolio? - TradingView

May 13, 2025
pulisher
May 13, 2025

Oncologists Report Seeing More Advanced Cancers and Say Current Tests Are Not Catching Cancer Recurrence Early Enough, New Quest Diagnostics Report Finds - Quantisnow

May 13, 2025
pulisher
May 08, 2025

Global Immunodiagnostics Market to Cross the USD 32 Billion by 2032 | DelveInsight - GlobeNewswire Inc.

May 08, 2025
pulisher
May 06, 2025

Quest Diagnostics (DGX) Sees Raised Target Price by JP Morgan | - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Nike To $70? Here Are 10 Top Analyst Forecasts For Tuesday - Benzinga

May 06, 2025
pulisher
May 06, 2025

Quest Diagnostics (DGX) Receives Price Target Increase from JPMo - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Take the Zacks Approach to Beat the Markets: ADMA Biologics, Limbach, Quest Diagnostics in Focus - MSN

May 06, 2025
pulisher
May 03, 2025

Quest Diagnostics Stock: A Leader But Waiting For Better Price (NYSE:DGX) - Seeking Alpha

May 03, 2025
pulisher
May 02, 2025

Quest Settles Fired Black Phlebotomist's Retaliation Suit - Law360

May 02, 2025
pulisher
May 01, 2025

Bullish on Quest Diagnosis Inc. - The Globe and Mail

May 01, 2025
pulisher
Apr 30, 2025

This Company Extended Its Post-Earnings Rally to Record Highs - The Globe and Mail

Apr 30, 2025
pulisher
Apr 29, 2025

Labcorp beats quarterly profit estimate on diagnostic test demand - Reuters

Apr 29, 2025
pulisher
Apr 28, 2025

Fitch elevates Quest Diagnostics’ rating to ’BBB+’ with stable outlook By Investing.com - Investing.com Canada

Apr 28, 2025
pulisher
Apr 28, 2025

Fitch elevates Quest Diagnostics’ rating to ’BBB+’ with stable outlook - Investing.com

Apr 28, 2025
pulisher
Apr 28, 2025

Piper Sandler Adjusts Price Target on Quest Diagnostics to $200 From $180, Maintains Neutral Rating - marketscreener.com

Apr 28, 2025
pulisher
Apr 26, 2025

Decoding Quest Diagnostics Inc (DGX): A Strategic SWOT Insight - GuruFocus

Apr 26, 2025
pulisher
Apr 24, 2025

Here's How Much You Would Have Made Owning Quest Diagnostics Stock In The Last 5 Years - Benzinga

Apr 24, 2025
pulisher
Apr 24, 2025

Truist Financial Keeps Their Hold Rating on Quest Diagnostics (DGX) - The Globe and Mail

Apr 24, 2025
pulisher
Apr 23, 2025

These Analysts Boost Their Forecasts On Quest Diagnostics After Better-Than-Expected Q1 Earnings - Benzinga

Apr 23, 2025
pulisher
Apr 23, 2025

Morgan Stanley Adjusts Quest Diagnostics Price Target to $182 From $172, Maintains Overweight Rating - marketscreener.com

Apr 23, 2025
pulisher
Apr 23, 2025

Baird Adjusts Quest Diagnostics Price Target to $194 From $191, Maintains Outperform Rating - marketscreener.com

Apr 23, 2025
pulisher
Apr 23, 2025

Jefferies Adjusts Quest Diagnostics Price Target to $195 From $190, Maintains Buy Rating - marketscreener.com

Apr 23, 2025
pulisher
Apr 23, 2025

Quest Diagnostics (DGX) Sees Price Target Increase Following Str - GuruFocus

Apr 23, 2025
pulisher
Apr 23, 2025

Mizuho Securities Adjusts Quest Diagnostics Price Target to $190 From $189 - marketscreener.com

Apr 23, 2025
pulisher
Apr 23, 2025

Quest Diagnostics (DGX) Sees Price Target Increase Following Strong Q1 Results | DGX Stock News - GuruFocus

Apr 23, 2025
pulisher
Apr 23, 2025

A Glimpse Into The Expert Outlook On Quest Diagnostics Through 12 Analysts - Benzinga

Apr 23, 2025
pulisher
Apr 23, 2025

Quest Diagnostics Incorporated (NYSE:DGX) Q1 2025 Earnings Call Transcript - Insider Monkey

Apr 23, 2025
pulisher
Apr 23, 2025

Truist Raises Price Target on Quest Diagnostics to $190 From $182, Keeps Hold Rating - marketscreener.com

Apr 23, 2025
pulisher
Apr 23, 2025

Quest Diagnostics (DGX) Sees Price Target Boost from Barclays | - GuruFocus

Apr 23, 2025

퀘스트 다이아그노스틱스 (DGX) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
diagnostics_research LH
$247.03
price down icon 0.27%
diagnostics_research WAT
$354.59
price down icon 1.05%
$161.21
price up icon 2.58%
diagnostics_research IQV
$138.78
price down icon 1.25%
diagnostics_research MTD
$1,157.50
price down icon 0.46%
자본화:     |  볼륨(24시간):